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Abstract
Background: Plasmodium falciparum malaria has been suspected to cause hearing loss. Developmental, cognitive and 
language disorders have been observed in children, surviving cerebral malaria. This prospective study aims to evaluate 
whether malaria influences hearing in mice.
Methods: Twenty mice were included in a standardized murine cerebral malaria model. Auditory evoked brainstem 
responses were assessed before infection and at the peak of the illness.
Results: A significant hearing impairment could be demonstrated in mice with malaria, especially the cerebral form. 
The control group did not show any alterations. No therapy was used.
Conclusion: This suggests that malaria itself leads to a hearing impairment in mice.
Background
With more than 247 million cases in 2006 malaria is one
of the most frequent infectious diseases world wide[1].
The most severe course of the human disease is caused by
Plasmodium falciparum, leading to multi-organ disease.
In particular cerebral malaria (CM) is potentially leading
to a wide range of neurocognitive sequelae[2]. Further-
more, it has been shown that severe falciparum malaria
may lead to an acquired language disorder[2].
Language development in childhood needs an intact
and perfectly functioning hearing system - from the outer
ear canal to the sensory cerebral cortex. So far, in malaria
research no dedicated and specific attention has been
paid to the involvement of the inner ear. Only very few
authors have reported an acquired hearing impairment
possibly caused by falciparum malaria[3,4]. To shed light
into this aspect, a cerebral malaria experiment in Plasmo-
dium berghei ANKA infected C57BL/6J mice - a well
defined model for severe/cerebral malaria - was per-
formed evaluating the hearing threashold with auditory
evoked brain stem responses (ABRs) before infection and
at the peak of the disease[5,6].
The primary aim of this study was to evaluate a possible
change of the hearing threshold in mice with CM and
malaria without cerebral involvement.
Methods
Study design
The animal study conformed to the Austrian guidelines
for the care and use of laboratory animals and were
approved by the Austrian Ministry for Education, Science
and Culture with the reference number do. Zl. A08/4102.
Three different animal groups were studied. One group
contains the mice suffering from cerebral malaria (CM).
The second group contains mice, which are infected with
malaria, show a parasitaemia comparable to the cerebral
malaria mice, but did not develop a cerebral involvement
(non-CM). The third group were healthy non-infected
animals, which were kept at equal housing, environmen-
tal and experimental conditions.
Prior to infection a baseline hearing test with ABRs was
performed for the frequencies 8 kHz, 13 kHz, 36 kHz and
a click sound. Only animals with clearly evokable and
readable initial ABRs were included into the study and
infected on the same day.
To monitor the course of the disease the mice were sub-
jected to a daily evaluation of the SHIRPA score. The CM
group is expected to develop signs and symptoms
* Correspondence: Joachim.Schmutzhard@i-med.ac.at
1 Department of Otorhinolaryngology, Innsbruck Medical University, 
Anichstraße 35, 6020 Innsbruck Austria
Full list of author information is available at the end of the articleSchmutzhard et al. Malaria Journal 2010, 9:159
http://www.malariajournal.com/content/9/1/159
Page 2 of 5
between day 5 and 11 after infection. At the peak of the
cerebral disease a second ABR measurement was per-
formed and thereafter the animals were sacrificed. Ani-
mals surviving day 10 do not develop CM anymore [6].
These animals were used as the non-CM control group
and, the second ABR measurement was done on the 11th
day immediately before sacrification.
The results of the ABR were compared between groups
and to the baseline data.
After the ABR measurements the CM mice were sacri-
ficed and their brains examined for vascular affection.
Auditory brainstem responses
The auditory brain stem responses were measured with
ABR machine provided by ZLE - Systemtechnik©,
Munich Germany. Three frequencies 8 kHz, 13 kHz, 36
kHz and a click sound were measured to evaluate the
hearing threshold. The right ear of each mouse was
examined. Subsequently the ABRs were measured in an
electrically shielded sound attenuating chamber. The
potentials are gained by means of three subcutaneous
needle-electrodes. The positive electrode is placed at the
vertex, the negative electrode at the bulla and the ground
electrode at the ipsilateral leg. Tones of 8, 13, 36 kHz and
a click sound are used as stimuli. The clicks are produced
by two different transducers. Starting with 80 dB the
stimuli are decreased by 10 dB. The ABR thresholds are
determined as the minimum stimulation level, that pro-
duces a clearly recognisable potential. The signals are
amplified by a physiologic amplifier and filtered. The
responses of 500 stimuli are averaged by means of com-
puterized data acquisition synchronized to stimulus
onset. The resulting wave responses were interpreted in a
blinded manner by two independent ENT-specialists (JS,
ASF).
The anesthesia is performed with an Ohmeda Isotec 5
Vaporisator (Duisburg, Germany). With a continuous
flow of 3 l/minute oxygen 1% isoflourane is vaporized.
The nose and mouth of the mouse are loosly fitted into
the dispenser mask. The excess anaestetic and air is dis-
posed of by wide loomed noiseless suction.
Animal model
Six to eight week old C57BL/6J mice (Charles River Labo-
ratories, Sulzfeld, Germany) are used as cerebral malaria
susceptible strains. The mice are housed under standard
conditions in the animal housing facility of the Medical
University Innsbruck, Austria. After an accommodation
period for approximately three to five days, the animals
are taken for the study. The C57BL/6J mouse is a strain
susceptible to blood stages of P. berghei ANKA. After the
determination of the ABR thresholds as described above,
the mice are infected with an intraperitoneal application
of 1 × 106  parasitized erythrocytes of a homologous
donor, which had been infected with frozen polyclonal
stocks of P. berghei [7]. The parasitaemia was monitored
by daily blood smears of tail blood. The smears are
stained by Wright stain.
The progress of the disease was evaluated with the
SHIRPA score as described by Lackner et al [6]. The
SHIRPA score is a behavioural screening battery consist-
ing of 40 simple tests, which are arranged in the five sub-
groups: reflex and sensory function, neuropsychiatric
state, motor behaviour, autonomous function, muscle
tone and strength. A total SHIRPA score below 15 is con-
sidered as severe cerebral malaria, between 15 and 25 as
moderate and above 25 as mild [8]. When typical signs
and symptoms of cerebral malaria, like convulsions,
paralysis and coma appear, the mice are considered at the
peak of the disease.
Histologic workup
After the ABR measurement the deeply anaesthesized
animals were sacrificed by an intraperitoneal thiopental
overdose for futher histological workup. The fixation and
histologic work-up was done according to a standard pro-
cedure as described by Lackner [6].
Statistical evaluation
The statistical work up was done with SPSS (v.17.0, Chi-
cago, USA). The baseline measurement and the second
measurement was compared with the Wilcoxon signed
rank sum test. This procedure was done for each group
separately. The graphical presentation of the data was
done with Graphpad Prism 5.01 (Graphpad Softwarein-
corporation, La Jolla, USA).
Results
Thirty C57BL/6J mice were included into the study. After
baseline measurement 29 mice were included into the
study. One mouse showed - at the initial measurement - a
pathological hearing threshold and was excluded.
Twenty mice were infected as described above and all
developed similar parasitaemia. Out of these 20 mice ten
developed cerebral malaria (CM) and 10 did not develop
a cerebral manifestation (non-CM).
The CM group showed an average SHIRPA score of
28.7 at the start of the study, which decreased to an aver-
age of 16.5 points. Three of the mice developed a severe
CM with a SHIRPA score below 15. With a scoring
between 15.9 and 21.6 the other mice could be judged as
moderate CM. No animal was in the mild CM group.
The non CM group scored an average of 28.2 SHIRPA
points at the beginning of the study and decreased to an
average of 25.4 at the timepoint of the second measure-
ment. Five of the the non CM mice showed a mild tempo-
rary drop in the SHIRPA score, stabilizing at a lower level.Schmutzhard et al. Malaria Journal 2010, 9:159
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The healthy control group was not retested, all mice
remained in a stable condition.
Six mice of the CM group developed various degrees of
hearing impairment with a maximum loss of up to 40 dB
in various frequencies. (Figure 1, 2a-d) The animals with
the most severe hearing impairment were categorized as
severe CM with a Shirpa scoring under 15. The statistical
analysis of the CM group revealed a significant alteration
of the hearing threshold in the frequences 8 kHz (p =
0.047) and 36 kHz (p = 0.023), a trend could be demon-
strated for 13 kHz (p = 0.059). No change was found for
the click sound.
The non-CM group consisted of 10 mice. Seven of
these animals developed a hearing loss up to 20 dB in the
various frequencies comparing the baseline and the mea-
surement on day 11. All five non CM mice with a
recorded temporary drop of the SHIRPA score showed
this hearing impairment. The statistical evaluation of the
non-CM group showed a significant hearing impairment
at frequency 8 kHz (p = 0.014) and a trend at the fre-
quency 13 kHz (p = 0.059). No significant alteration was
marked for 36 kHz and Click.
Nine mice served as control group. At both timepoints
of measurement no significant hearing alterations could
be detected in all evaluated frequences (Figure 2e-f). Six
times a decrease of 10 dB could be noted and six times an
increase of 10 dB in all measured frequences.
The histological examination of all ten CM mice
showed the expected vascular affection with parenchy-
mal microhaemorrhages and leukocyte sequestration
(Figure 3) confirming the cerebral manifestation.
Discussion
The existence of a malaria related hearing loss has been
suspected in African CM children without quantifying
Figure 1 shows an example of the ABR findings at the frequency 
of 13 kHz in a cerebral malaria mouse. Test 1 represents the baseline 
measurement. Test 2 is the ABR finding at the peak of the cerebral ma-
laria. The red circles indicate the last positive counted wave. Therefore 
a hearing threshold of 20 dB SPL is counted in test 1 and a threshold of 
60 dB in test 2. (SPL:Sound Pressure Level)
Figure 2 shows the audiologic results of the CM group and the 
healthy control group. a-d) represent the CM group. Test 1 is done at 
baseline screening. Test two at the peak of the clinical disease. e-f) list 
the findings of the control group. Test 1 is done at baseline screening. 
Test two at the 11th day after the primary testing.
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the burden of the problem nor addressing the pathophys-
iological basis[3,4]. This study demonstrates in a pro-
spective way, that malaria leads to a significant hearing
impairment in mice. When comparing the results of the
different subgroups an affection at all measured frequen-
cies could been shown in the CM group, but only at the
lower and middle frequencies in the non-CM group, as
expected the control did not show any significant hearing
alterations.
The cerebral affection of the measured animals was
confirmed by histology.
Zheng et al [9] described the hearing threshold for the
C57BL/6J mouse on a similar level as found in the base-
line ABR proving the quality of the the experimental set-
up. The anesthesia used in Zhengs study was an intrap-
eritoneal injection of ketamine and xylazine. Most studies
evaluating ABR use an intraperitoneal injection to avoid a
possible negative influence of isofluorane on the ABR
results. Isoflourane has been described to lead to a signif-
icant latency increasement, but does not influence the
amplitude in rats[10]. Aware of these possible side effects,
the isofluorane anesthesia was chosen, which can be con-
trolled much easier, to avoid an accidental early death of
these very sick animals at the timepoint of the second
ABR testing.
The pathophysiological processes leading to these find-
ings are unclear. The ABR results show an equal decrease
of the amplitudes in all measured peaks. A pathologic
alteration of the brain stem and the upper audiologic cen-
ters would result in a decrease of the amplitude of peak
three to five, whereas the peak one and two should not be
affected [11]. Therefore a pathologic alteration of the
brain stem is highly unlikely
Malaria retinopathy has been suggested to be the result
of adherence and sequestration of P. falciparum-infected
erythrocytes in the microvascular system leading to
impaired microcirculation [12]. The anatomical situation
of the ocular and the inner ear perfusion is similar. Both
the ophthalmic artery and the labyrinth artery originate
from cerebral vessels. Thus, it seems conceivable that
impairment of cerebral microcirculation within the cen-
tral nervous system is very likely to include both organs
[8]. The spiral modiular artery enters the cochlea at the
basal turn and ends at the apical turn [13]. Therefore, dis-
turbances of the microvascular system and impairment of
perfusion of the cochlea should effect the apical turns
more than the basal. With a significant hearingloss at 8
kHz - a frequency which is located more apically in the
cochlea -the hypothesis of a microvasvular affection in
the CM group is supported. The non-CM group with a
significant impairment of the lower and middle frequen-
cies suggests an equivalent interpretation possibility.
The majority of the animals (five of seven) with hearing
impairment did show a mild temporary drop in the
SHIRPA score, suggesting a mild cerebral/vascular affec-
tion as described by Cabrales et al.[6,14]. This circum-
stance further supports the hypothesis that the vascular
pathophysiology in cerebral malaria leads to an affection
of the inner ear. To clarify this pathophysiological con-
cept additional studies in other non-CM models are
required.
The affection at 36 kHz, a frequency which is located at
a more basal turn of the cochlea, and the minor affection
of the more apically positioned 13 kHz is hardly explain-
able by this interpretation. Other pathologic alterations
are known to affect the inner ear with various inflamma-
tory mediators [15]. A similar effect onto the inner ear
could be possible since it has been shown that a wide
variety of inflammatory mediators are released during the
course of CM or severe malaria, respectively. For exam-
ple, an increase of the soluble Endoglin has been shown
in severe malaria [16]. Endoglin is a co-receptor of the
TGF- beta system [16]. Satoh et al showed an involve-
m e n t  o f  t h i s  T G F - be t a  s y s t e m  i n  t h e  c oc h l e a  i m m u n e
response [17] rendering this hypothesis - that various
inflammatory mediators of malaria also affect the inner
ear.
Furthermore, P. falciparum malaria is known to cause
language disorders in children [2]. This clinical finding
has been suggested to be a consequence of cerebral
injury. Carter et al [2], when discussing these findings,
did not list any audiologic testing nor any hearing thresh-
olds. In early childhood, i.e. during the period of language
development, hearing impairment is known to cause a
Figure 3 shows the histology of the brain of a mouse with cere-
bral malaria and hearing impairment. The typical signs of leucocyte 
sequestration (a) and microhaemorrhages (b) are shown. (Hematoxilin 
Eosin staining; magnification 400 ×)
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retardation or, even, impairment of the language develop-
ment [18].
Summarizing, malaria, especially the cerebral form, has
been shown to cause hearing impairment in the murine
malaria model. Further studies are nescessary to under-
stand the pathophysiological alterations in the inner ear
and to evaluate the impact of these findings for humans.
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